Key Indices


Top Stories
Small/Mid Cap Highlights | KB Bukopin (BBKP IJ/NOT RATED/Rp41)
- BBKP's operating recovery is gaining traction, supported by lower funding costs, improving NIM and wholesale loan growth. However, profitability remains modest, while elevated legacy NPLs and potential restructuring costs continue to constrain capital generation. BBKP currently trades at 0.9x P/B, with sustainable earnings recovery and further asset-quality improvement remaining key factors in its valuation outlook. Amid speculation over the cooperative acquisition, BBKP confirmed that no discussions have taken place, while OJK stated that it has not received any formal proposal.
Technical Analysis
Summarecon Agung | SMRA IJ
- Trading Buy Range: We have a technical Buy at Rp254, and take profit at Rp274.
Elnusa | ELSA IJ
- Trading Buy Range: We have a technical Buy at Rp650, and take profit at Rp700.
Top Stories
Small/Mid Cap Highlights | KB Bukopin (BBKP IJ/NOT RATED/Rp41)
- BBKP's operating recovery is gaining traction, supported by lower funding costs, improving NIM and wholesale loan growth. However, profitability remains modest, while elevated legacy NPLs and potential restructuring costs continue to constrain capital generation. BBKP currently trades at 0.9x P/B, with sustainable earnings recovery and further asset-quality improvement remaining key factors in its valuation outlook. Amid speculation over the cooperative acquisition, BBKP confirmed that no discussions have taken place, while OJK stated that it has not received any formal proposal.
Technical Analysis
Summarecon Agung | SMRA IJ
- Trading Buy Range: We have a technical Buy at Rp254, and take profit at Rp274.
Elnusa | ELSA IJ
- Trading Buy Range: We have a technical Buy at Rp650, and take profit at Rp700.
Key Indices


IMPORTANT NOTICE - DISCLOSURES AND DISCLAIMERS
This report is provided subject to, and must be read together with, the full Disclosures / Disclaimers available at this link, which are incorporated by reference into this report. In particular, this report is intended for general circulation and informational purposes only and does not constitute personal investment advice or a recommendation to buy or sell any investment product or security. You should independently evaluate the information and, where necessary, seek advice from a qualified financial adviser regarding the suitability of any investment. Analyst certifications required under applicable regulations, including SEC Regulation AC (where relevant), are included in this report. By accessing, receiving or using this report, you acknowledge that you have read, understood and agreed to be bound by the Disclosures / Disclaimers, as may be amended, supplemented or updated from time to time.



